GetTopicDetailResponse(id=8818813337b, topicName=肝素抗凝程度, introduction=肝素抗凝程度, content=null, image=null, comments=1, allHits=923, url=https://h5.medsci.cn/topic?id=81333, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99411, tagList=[TagDto(tagId=99411, tagName=肝素抗凝程度)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2058946, encodeId=921b205894626, content=<a href='/topic/show?id=8818813337b' target=_blank style='color:#2F92EE;'>#肝素抗凝程度#</a>, objectTitle=EUR HEART J-CARD PHA：接受PCI治療的心肌梗死患者接受無規(guī)劃糖蛋白IIb/IIIa抑制劑的p2y12抑制劑患者的肝素抗凝程度與臨床結(jié)果的關(guān)系, objectType=article, longId=187475, objectId=0c5518e475ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c5518e475ae, replyNumber=0, likeNumber=95, createdTime=2020-05-21, rootId=0, userName=839640778, userId=45b2276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c5518e475ae, moduleTitle=EUR HEART J-CARD PHA：接受PCI治療的心肌梗死患者接受無規(guī)劃糖蛋白IIb/IIIa抑制劑的p2y12抑制劑患者的肝素抗凝程度與臨床結(jié)果的關(guān)系, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0c5518e475ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
